RECORD // Company

Medline Inc.

Built 2026-11-22T00:19:34Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (3)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • MEDLINE · Epa echo · name equals 'Medline' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • MEDLINE · Epa echo · name equals 'Medline' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • MEDLINE · Epa echo · name equals 'Medline' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare

8 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-26, filed 2026-11-04 · accession 0002046386-26-000063

ItemValuePeriodFormFiledAccessionReport
Revenue$7,856,000,0003 months ended 2026-09-2610-Q2026-11-040002046386-26-0000632026-11-22 00:19 UTCReport an error
Net income (loss)$318,000,0003 months ended 2026-09-2610-Q2026-11-040002046386-26-0000632026-11-22 00:19 UTCReport an error
Interest expense$165,000,0003 months ended 2026-09-2610-Q2026-11-040002046386-26-0000632026-11-22 00:19 UTCReport an error
Cash and cash equivalents$2,321,000,000at 2026-09-2610-Q2026-11-040002046386-26-0000632026-11-22 00:19 UTCReport an error
Debt due in the next 12 months$28,000,000at 2026-09-2610-Q2026-11-040002046386-26-0000632026-11-22 00:19 UTCReport an error
Debt due in year 2$27,000,000at 2026-09-2610-Q2026-11-040002046386-26-0000632026-11-22 00:19 UTCReport an error
Debt due in year 3$8,027,000,000at 2026-09-2610-Q2026-11-040002046386-26-0000632026-11-22 00:19 UTCReport an error
Debt due in year 4$28,000,000at 2026-09-2610-Q2026-11-040002046386-26-0000632026-11-22 00:19 UTCReport an error

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0002046386
Ticker
MDLN
EIN
331845288
CUSIP
58507V107
Record ID
sx:sec:0002046386

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

31 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-19SEC EDGAR company profile2026-11-22 00:19 UTCReport an error
SIC industry3841 Surgical & Medical Instruments & Apparatus2026-11-19SEC EDGAR company profile2026-11-22 00:19 UTCReport an error
State of incorporationDE2026-11-19SEC EDGAR company profile2026-11-22 00:19 UTCReport an error
Fiscal year end (MMDD)12312026-11-19SEC EDGAR company profile2026-11-22 00:19 UTCReport an error
Business address3 LAKES DRIVE, NORTHFIELD, IL, 600932026-11-19SEC EDGAR company profile2026-11-22 00:19 UTCReport an error
ExchangesNasdaq2026-11-19SEC EDGAR company profile2026-11-22 00:19 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$28,432,000,0002025-12-3110-K, XBRL Revenues2026-11-22 00:19 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$1,159,000,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 00:19 UTCReport an error
Total assets (at 2025-12-31)$38,484,000,0002025-12-3110-K, XBRL Assets2026-11-22 00:19 UTCReport an error
Stockholders' equity (at 2025-12-31)$10,737,000,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 00:19 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$1,939,000,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 00:19 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$1,744,000,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 00:19 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$447,000,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 00:19 UTCReport an error
Long-term debt (at 2025-12-31)$12,484,000,0002025-12-3110-K, XBRL LongTermDebtNoncurrent2026-11-22 00:19 UTCReport an error
Operating lease liabilities (at 2025-12-31)$452,000,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 00:19 UTCReport an error
Unrecorded purchase obligations (at 2025-12-31)$312,000,0002025-12-3110-K, XBRL UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount2026-11-22 00:19 UTCReport an error
8-K Item 1.01, Entry into a Material Definitive Agreement (filed 2026-11-18)On November 16, 2026, Medline Inc. (the “Company”) and Medline Holdings, LP (“Medline Holdings”) entered into a share and unit repurchase agreement (the “Repurchase Agreement”) with certain entities affiliated with Blackstone Inc., The Carlyle Group Inc., and Hellman & Friedman LLC, along with GIC Private Limited and its managed affiliate and a wholly owned subsidiary of the Abu Dhabi Investment Authority (collectively, the “Selling Stockholders”), pursuant to which the Company and Medline Holdings agreed to repurchase directly from the Selling Stockholders an aggregate of $200 million of Class A common stock of the Company and limited partnership interests of Medline Holdings (“Common…2026-11-18SEC EDGAR 8-K 0001193125-26-467193 (text as filed, excerpt)2026-11-22 00:19 UTCReport an error
8-K Item 8.01, Other Events (filed 2026-11-18)On November 17, 2026, the Company issued a press release that announced the pricing of an underwritten secondary offering (the “Offering”) of 60,000,000 shares of the Company’s Class A common stock (the “Shares”). The Shares were offered by the Selling Stockholders, and the Offering is expected to result in net proceeds to the Selling Stockholders of approximately $2.1 billion (excluding any exercise of the underwriters’ 30-day option to purchase up to an additional 9,000,000 Shares). The Offering is expected to close on November 23, 2026, subject to customary closing conditions. A copy of the press release is filed as Exhibit 99.1 hereto and is incorporated herein by reference.2026-11-18SEC EDGAR 8-K 0001193125-26-467193 (text as filed, excerpt)2026-11-22 00:19 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-04)On November 4, 2026, Medline Inc. issued a press release announcing results for the third quarter and the first nine months ended September 26, 2026. A copy of this press release is furnished as Exhibit 99.1 hereto. The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of, or otherwise regarded as filed under, the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or in the Exchange Act, except as shall be expressly set forth by specific reference in such filing.2026-11-04SEC EDGAR 8-K 0002046386-26-000060 (text as filed, excerpt)2026-11-22 00:19 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-10-21)On October 14, 2026, Medline Inc. (the “Company”) initiated a voluntary field action involving the removal, discontinuation, and market exit of all Medline Brand beds, including homecare beds, bariatric beds, and long-term care beds, as well as their associated pendants, accessories, replacement parts, and bed-containing order packages. The affected products are within the Company’s Front Line Care product category in the Company’s Medline Brand segment. Net sales of the affected products for the twelve months ended June 27, 2026, were approximately $60 million. While it is too early to ascertain the total costs associated with the field action, including product discontinuation, inclusive…2026-10-21SEC EDGAR 8-K 0001104659-26-117844 (text as filed, excerpt)2026-11-22 00:19 UTCReport an error
8-K Item 5.02, Departure of Directors or Certain (filed 2026-10-15)Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 13, 2026, Joseph P. Baratta notified the Board of Directors (the “Board”) of Medline Inc. (the “Company”) of his decision to resign from the Board, effective as of December 31, 2026. Mr. Baratta’s decision coincides with his previously announced departure from Blackstone Inc. and is not the result of any disagreement with the Company related to the Company’s operations, policies, or practices. The Board is grateful for Mr. Baratta’s service and contributions to the Company.2026-10-15SEC EDGAR 8-K 0001104659-26-116255 (text as filed, excerpt)2026-11-22 00:19 UTCReport an error
Largest institutional holder #1 (13F as filed): Carlyle Group Inc.$7,378,581,6412026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:19 UTCReport an error
Largest institutional holder #2 (13F as filed): H&F Corporate Investors X, Ltd.$2,795,283,4172026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:19 UTCReport an error
Largest institutional holder #3 (13F as filed): FMR LLC$1,852,228,7532026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:19 UTCReport an error
Largest institutional holder #4 (13F as filed): Capital Research Global Investors$1,576,182,7982026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:19 UTCReport an error
Largest institutional holder #5 (13F as filed): Invesco Ltd.$1,512,403,2102026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:19 UTCReport an error
Largest institutional holder #6 (13F as filed): BlackRock, Inc.$1,040,963,0632026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:19 UTCReport an error
Largest institutional holder #7 (13F as filed): LONE PINE CAPITAL LLC$826,992,3942026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:19 UTCReport an error
Largest institutional holder #8 (13F as filed): MASSACHUSETTS FINANCIAL SERVICES CO /MA/$787,117,0992026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:19 UTCReport an error
Largest institutional holder #9 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$702,665,2882026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:19 UTCReport an error
Largest institutional holder #10 (13F as filed): VANGUARD PORTFOLIO MANAGEMENT LLC$661,843,8632026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:19 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.